Single step encapsulation process of tamoxifen in biodegradable polymer using supercritical anti-solvent (SAS) process

[1]  A. Nokhodchi,et al.  Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement. , 2016, Colloids and surfaces. B, Biointerfaces.

[2]  Y. Zu,et al.  Preparation of inclusion complex of apigenin-hydroxypropyl-β-cyclodextrin by using supercritical antisolvent process for dissolution and bioavailability enhancement. , 2016, International journal of pharmaceutics.

[3]  E. Adeli.  The use of supercritical anti-solvent (SAS) technique for preparation of Irbesartan-Pluronic® F-127 nanoparticles to improve the drug dissolution , 2016 .

[4]  F. Ahmad,et al.  Experimental investigation and oral bioavailability enhancement of nano-sized curcumin by using supercritical anti-solvent process. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  B. Mukherjee,et al.  Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy , 2014, International journal of nanomedicine.

[6]  Amit Jain,et al.  Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity. , 2013, Molecular pharmaceutics.

[7]  Shinji Kanehashi,et al.  Effects of various liquid organic solvents on solvent-induced crystallization of amorphous poly(lactic acid) film , 2013 .

[8]  Lei Yang,et al.  Physicochemical properties and oral bioavailability of ursolic acid nanoparticles using supercritical anti-solvent (SAS) process. , 2012, Food chemistry.

[9]  R. Yunus,et al.  Application of supercritical antisolvent method in drug encapsulation: a review , 2011, International journal of nanomedicine.

[10]  M. Trotta,et al.  Poly(amidoamine)-Cholesterol Conjugate Nanoparticles Obtained by Electrospraying as Novel Tamoxifen Delivery System , 2011, Journal of drug delivery.

[11]  A. Salehzadeh,et al.  Delivering tamoxifen within solid lipid nanoparticles , 2011 .

[12]  F. Giordano,et al.  Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals. , 2008, Advanced drug delivery reviews.

[13]  M. Amiji,et al.  Poly(ethylene oxide)-modified poly(ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer , 2005 .

[14]  B. Shekunov,et al.  Supercritical fluid technology for drug product development , 2004 .

[15]  H. Hollema,et al.  TAMOXIFEN TREATMENT AND GYNECOLOGIC SIDE EFFECTS: A REVIEW , 2001, Obstetrics and gynecology.

[16]  Bruno C. Hancock,et al.  What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.

[17]  V. Jordan.  Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata. , 1976, European journal of cancer.

[18]  H. Okamoto,et al.  Acetaminophen particle design using chitosan and a spray-drying technique. , 2005, Chemical & pharmaceutical bulletin.

[19]  P. Angelberger,et al.  Distribution of 64Cu-bleomycin in normal and tumor-bearing rats. , 1976, European journal of cancer.